Header Logo

Connection

Jeff Slezak to Breast Neoplasms

This is a "connection" page, showing publications Jeff Slezak has written about Breast Neoplasms.
Connection Strength

0.462
  1. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer. Am J Clin Oncol. 2014 Oct; 37(5):486-91.
    View in: PubMed
    Score: 0.272
  2. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005 Nov 01; 23(31):7849-56.
    View in: PubMed
    Score: 0.036
  3. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer. 2003 Nov 15; 98(10):2152-60.
    View in: PubMed
    Score: 0.032
  4. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer. 2003 Jan 01; 97(1):1-11.
    View in: PubMed
    Score: 0.030
  5. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res. 2002 Jul 01; 62(13):3587-91.
    View in: PubMed
    Score: 0.029
  6. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001 Oct 01; 19(19):3938-43.
    View in: PubMed
    Score: 0.028
  7. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000 Jul 19; 284(3):319-24.
    View in: PubMed
    Score: 0.025
  8. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes Chromosomes Cancer. 2004 Sep; 41(1):1-11.
    View in: PubMed
    Score: 0.008

© 2024 Kaiser Permanente